The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Insulin API Market Research Report 2024

Global Insulin API Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1735191

No of Pages : 89

Ask Your Query

Synopsis

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

The global Insulin API market was valued at US$ 1745.6 million in 2023 and is anticipated to reach US$ 2137.4 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

This report aims to provide a comprehensive presentation of the global market for Insulin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin API.

Report Scope

The Insulin API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insulin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Novo Nordisk
  • Sanofi-Aventis
  • Eli Lilly
  • Tonghua Dongbao
  • Ganlee
  • United Laboratory
  • Biocon
  • Amphastar
  • Wockhardt
  • Julphar Diabetes
  • Torrent Pharma

Segment by Type

  • Regular Human Insulin
  • Insulin Analogue

Segment by Application

  • Fast-Acting
  • Premix
  • Long-Acting

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Insulin API Market Overview
1.1 Product Overview and Scope of Insulin API
1.2 Insulin API Segment by Type
1.2.1 Global Insulin API Market Value Comparison by Type (2024-2030)
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Insulin API Segment by Application
1.3.1 Global Insulin API Market Value by Application: (2024-2030)
1.3.2 Fast-Acting
1.3.3 Premix
1.3.4 Long-Acting
1.4 Global Insulin API Market Size Estimates and Forecasts
1.4.1 Global Insulin API Revenue 2019-2030
1.4.2 Global Insulin API Sales 2019-2030
1.4.3 Global Insulin API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin API Market Competition by Manufacturers
2.1 Global Insulin API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin API Average Price by Manufacturers (2019-2024)
2.4 Global Insulin API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin API, Product Type & Application
2.7 Insulin API Market Competitive Situation and Trends
2.7.1 Insulin API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin API Players Market Share by Revenue
2.7.3 Global Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin API Retrospective Market Scenario by Region
3.1 Global Insulin API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin API Global Insulin API Sales by Region: 2019-2030
3.2.1 Global Insulin API Sales by Region: 2019-2024
3.2.2 Global Insulin API Sales by Region: 2025-2030
3.3 Global Insulin API Global Insulin API Revenue by Region: 2019-2030
3.3.1 Global Insulin API Revenue by Region: 2019-2024
3.3.2 Global Insulin API Revenue by Region: 2025-2030
3.4 North America Insulin API Market Facts & Figures by Country
3.4.1 North America Insulin API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin API Sales by Country (2019-2030)
3.4.3 North America Insulin API Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin API Market Facts & Figures by Country
3.5.1 Europe Insulin API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin API Sales by Country (2019-2030)
3.5.3 Europe Insulin API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin API Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin API Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Insulin API Market Facts & Figures by Country
3.7.1 Latin America Insulin API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin API Sales by Country (2019-2030)
3.7.3 Latin America Insulin API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin API Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin API Sales by Type (2019-2030)
4.1.1 Global Insulin API Sales by Type (2019-2024)
4.1.2 Global Insulin API Sales by Type (2025-2030)
4.1.3 Global Insulin API Sales Market Share by Type (2019-2030)
4.2 Global Insulin API Revenue by Type (2019-2030)
4.2.1 Global Insulin API Revenue by Type (2019-2024)
4.2.2 Global Insulin API Revenue by Type (2025-2030)
4.2.3 Global Insulin API Revenue Market Share by Type (2019-2030)
4.3 Global Insulin API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin API Sales by Application (2019-2030)
5.1.1 Global Insulin API Sales by Application (2019-2024)
5.1.2 Global Insulin API Sales by Application (2025-2030)
5.1.3 Global Insulin API Sales Market Share by Application (2019-2030)
5.2 Global Insulin API Revenue by Application (2019-2030)
5.2.1 Global Insulin API Revenue by Application (2019-2024)
5.2.2 Global Insulin API Revenue by Application (2025-2030)
5.2.3 Global Insulin API Revenue Market Share by Application (2019-2030)
5.3 Global Insulin API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Insulin API Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi-Aventis
6.2.1 Sanofi-Aventis Corporation Information
6.2.2 Sanofi-Aventis Description and Business Overview
6.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Aventis Insulin API Product Portfolio
6.2.5 Sanofi-Aventis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Insulin API Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Tonghua Dongbao
6.4.1 Tonghua Dongbao Corporation Information
6.4.2 Tonghua Dongbao Description and Business Overview
6.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tonghua Dongbao Insulin API Product Portfolio
6.4.5 Tonghua Dongbao Recent Developments/Updates
6.5 Ganlee
6.5.1 Ganlee Corporation Information
6.5.2 Ganlee Description and Business Overview
6.5.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ganlee Insulin API Product Portfolio
6.5.5 Ganlee Recent Developments/Updates
6.6 United Laboratory
6.6.1 United Laboratory Corporation Information
6.6.2 United Laboratory Description and Business Overview
6.6.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 United Laboratory Insulin API Product Portfolio
6.6.5 United Laboratory Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biocon Insulin API Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Amphastar
6.8.1 Amphastar Corporation Information
6.8.2 Amphastar Description and Business Overview
6.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amphastar Insulin API Product Portfolio
6.8.5 Amphastar Recent Developments/Updates
6.9 Wockhardt
6.9.1 Wockhardt Corporation Information
6.9.2 Wockhardt Description and Business Overview
6.9.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Wockhardt Insulin API Product Portfolio
6.9.5 Wockhardt Recent Developments/Updates
6.10 Julphar Diabetes
6.10.1 Julphar Diabetes Corporation Information
6.10.2 Julphar Diabetes Description and Business Overview
6.10.3 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Julphar Diabetes Insulin API Product Portfolio
6.10.5 Julphar Diabetes Recent Developments/Updates
6.11 Torrent Pharma
6.11.1 Torrent Pharma Corporation Information
6.11.2 Torrent Pharma Insulin API Description and Business Overview
6.11.3 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Torrent Pharma Insulin API Product Portfolio
6.11.5 Torrent Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin API Industry Chain Analysis
7.2 Insulin API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin API Production Mode & Process
7.4 Insulin API Sales and Marketing
7.4.1 Insulin API Sales Channels
7.4.2 Insulin API Distributors
7.5 Insulin API Customers
8 Insulin API Market Dynamics
8.1 Insulin API Industry Trends
8.2 Insulin API Market Drivers
8.3 Insulin API Market Challenges
8.4 Insulin API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock